Received May 7, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | C47XX | — |
Hiberix liquid portion only administration; Hiberix liquid portion only administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 9-week-old female patient who received Hib (Hiberix) (batch number C47XX, expiry date 20-OCT-2026) for prophylaxis. On 12-FEB-2026, the patient received Hiberix. On 12-FEB-2026, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: Hiberix liquid portion only administration) and inappropriate dose of vaccine administered (Verbatim: Hiberix liquid portion only administration). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 27-APR-2026 Reporter wanted to know how to proceed with two patients that received only the diluent of Hiberix. She was not aware of which two of nine patients received it, thus, the adverse event details of each of those nine was taken. This case is one of the nine linked cases, reported by the same reporter.; Sender's Comments: US-GSK-US2026057340:Same reporter/Different patient US-GSK-US2026057334:Same reporter/Different patient US-GSK-US2026057667:Same reporter/Different patient US-GSK-US2026057338:Same reporter/Different patient US-GSK-US2026057336:Same reporter/Different patient US-GSK-US2026057333:Same reporter/Different patient US-GSK-US2026057337:Same reporter/Different patient US-GSK-US2026057335:Same reporter/Different patient US-GSK-US2026057340:Same reporter/Different patient